BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5727695)

  • 1. Hemodynamic effects of isoproterenol infusion. An experimental study of cardiac performance with special emphasis on coronary artery flow dynamics.
    Dedichen H; Schenk WG
    Arch Surg; 1968 Dec; 97(6):934-9. PubMed ID: 5727695
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
    McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock.
    Kuhn LA; Kline HJ; Goodman P; Johnson CD; Marano AJ
    Am Heart J; 1969 Jun; 77(6):772-83. PubMed ID: 5770150
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic and coronary hemodynamic effects of glucagon.
    Rowe GG
    Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
    [No Abstract]   [Full Text] [Related]  

  • 6. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of endotoxin on myocardial hemodynamics, performance, and metabolism during beta adrenergic blockade.
    Hinshaw LB; Greenfeild LJ; Archer LT; Guenter CA
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1217-24. PubMed ID: 4400322
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG; Spring DA; Afonso S
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of beta-adrenergic blockade on myocardial haemodynamics and metabolism during light halothane anaesthesia.
    Merin RG; Tonnesen AS
    Can Anaesth Soc J; 1969 Jul; 16(4):336-44. PubMed ID: 5807476
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG; Terry W; Stenlund RR; Thomsen JH; Querimit AS
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoproterenol, hemodynamics and acid-base alterations.
    Greenburg AG; Dreisin RB; Wu G; Kittle CF
    Arch Surg; 1969 Dec; 99(6):744-9. PubMed ID: 5370198
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and coronary hemodynamic effects of intracoronary administration of prostaglandins E1 and E2.
    Rowe GG; Afonso S
    Am Heart J; 1974 Jul; 88(1):51-60. PubMed ID: 4152040
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of isoproterenol and 1-norepinephrine on function, coronary flow, and oxygen consumption of the intact left ventricle.
    Abe T; Malik AB; O'Kane HO; Geha AS
    Surgery; 1973 Oct; 74(4):562-9. PubMed ID: 4729221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental research on the coronary dilatory action of benzydryl-1-piperonylpiperazine in the intact dog].
    Laubie M; Schmitt H
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):1-6. PubMed ID: 5834935
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of isoproterenol and noradrenalin in experimental shock.
    Dedichen H; Schenk WG
    Acta Chir Scand; 1973; 139(3):213-8. PubMed ID: 4698482
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of prostaglandin A 1 on cardiovascular dynamics and myocardial metabolism.
    Barner HB; Kaiser GC; Hahn JW; Jellinek M; Amako H; Lee JB; Willman VL
    J Surg Res; 1972 Mar; 12(3):168-72. PubMed ID: 5020462
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary and hemodynamic effects of myocardio-selective beta-receptor blockade by ICI 50172 in the closed-chest dog. Differentiation of coronary and myocardial beta receptors.
    Bussmann WD; Rauh M; Krayenbuehl HP
    Am Heart J; 1970 Mar; 79(3):347-60. PubMed ID: 4391727
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a digitalis glycoside on coronary and systemic dynamics in conscious dogs.
    Vatner SF; Higgins CB; Franklin D; Braunwald E
    Circ Res; 1971 Apr; 28(4):470-9. PubMed ID: 5551895
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of glucagon on cardiac hemodynamics, coronary circulation and myocardial metabolism in humans].
    Warembourg H; Houdas Y; Bertrand ME; Ketelers JY; Vermeersch M
    Arch Mal Coeur Vaiss; 1969 Aug; 62(8):1080-95. PubMed ID: 4983769
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;
    Luz PL; Forrester JS; Wyatt HL; Tyberg JV; Chagrasulis R; Parmley WW; Swan HJ
    Circulation; 1975 Sep; 52(3):400-7. PubMed ID: 1157236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.